Table 2.
Observed3 | Expected4 | Observed-Expected Difference | Observed-Expected per 1,000 | Observed to Expected ratio | |
---|---|---|---|---|---|
25 dB1 | |||||
Total NNE | 6,052 | 6,059 | −7 | − 0.01 | 1.00 |
By Payer: | |||||
Medicaid | 2,960 | 3,121 | − 161 | −0.19 | 0.95 |
Commercial | 3,092 | 2,938 | + 154 | + 0.19 | 1.05 |
Total England | 66,414 | 123,797 | − 57,383 | − 3.41 | 0.54 |
20db2 | |||||
Total NNE | 6,052 | 7,963 | −1,911 | − 3.27 | 0.76 |
By Payer: | |||||
Medicaid | 2,960 | 4,102 | −1,142 | −1.39 | 0.72 |
Commercial | 3,092 | 3,861 | −769 | −0.93 | 0.80 |
Total England | 66,414 | 162,705 | − 96,291 | − 5.82 | 0.41 |
Hearing threshold guideline recommended by NICE guidance in England.
Hearing threshold guideline recommended by AAP guidance in the US.
Four-year observed number of tympanostomy tubes provided in the study period. These counts are the same for both 20dB and 25 dB observed to expected ratios.
Four-year expected number of tympanostomy tubes provided, estimated by an epidemiological model. (See Appendix)